Home / Health / Elekta Evo: AI to Fight Cancer in India
Elekta Evo: AI to Fight Cancer in India
28 Nov
Summary
- Elekta launches advanced AI-enabled CT-Linac, Elekta Evo.
- The technology enhances adaptive radiotherapy for precision cancer treatment.
- Launch occurs at the Association of Radiation Oncologists of India conference.
Elekta, a leader in precision radiation therapy, is set to introduce Elekta Evo, an advanced AI-enabled CT-Linac, in India. This cutting-edge technology will be unveiled at the Association of Radiation Oncologists of India conference in Kolkata, from November 28-30, 2025. Elekta Evo is designed to bolster adaptive radiotherapy (ART), a crucial approach for managing India's growing cancer burden.
Adaptive radiotherapy allows for real-time adjustments to treatment based on a tumor's changing characteristics. This personalization ensures radiation is precisely targeted, enhancing treatment efficacy and patient safety while minimizing potential side effects. Such advancements are particularly vital in India, addressing high rates of head and neck, breast, cervical, and prostate cancers.
With over 1.4 million cancer cases annually, many diagnosed late, ART represents a significant benefit. Elekta's commitment to improving cancer care globally is underscored by this launch, aiming to provide more patients with access to advanced, outcome-driven solutions and bring renewed hope.
